Singapore Medical Group

SMG's CEO Beng and party raise takeover offer to 40 cents - THE EDGE SINGAPORE

Offer

SMG's CEO Beng and party raise takeover offer to 40 cents

UOB Kay Hian on Sept 22 urged shareholders to reject the original offer of 37 cents per share
SMG’s CEO, non-executive chairman and executive director make 37 cents per share privatisation bid for company - THE EDGE SINGAPORE

Offer

SMG’s CEO, non-executive chairman and executive director make 37 cents per share privatisation bid for company

The cash price is a premium of 18.1% over the one-month VWAP of SMG's shares traded on the SGX.

Broker's Calls

935 Brokers' Digest

Here are three stocks to watch for the week: Dasin Retail Trust, ComfortDelGro and Singapore Medical Group.

Healthcare

Healthcare stocks get a shot in the arm as Wuhan virus fears rise

Private outpatient medical service provider Healthway Medical Corporation led the way on Tuesday, surging 42.9% to a new 52-week-high of 4 cents as at 12pm. But other SGX-listed healthcare stocks are also on the rise.

Update

Singapore Medical Group announces $50 mil share purchase from existing shareholder CHA

SINGAPORE (Feb 20): Singapore Medical Group (SMG) says its 6.86% shareholder CHA Healthcare Singapore (CHAS) is increasing its stake in the group to 24.13% by purchasing existing shares from certain SMG shareholders via a $50 million investment.  

Tech

Singapore Medical Group subsidiary launches telehealth platform HiDoc

SINGAPORE (Jan 31): Singapore Medical Group (SMG) subsidiary HiDoc today launched its new telehealth platform, which is meant to provide first-of-its-kind telehealth and video conferencing services while giving accredited specialists access to patient hea

M&A

Singapore Medical Group acquires 85% of SW1 Clinic for $6.5 mil

SINGAPORE (Mar 1): Singapore Medical Group (SMG) is acquiring an 85% stake in Pheniks for $6.5 million from two parties – Kenneth Lee Cheng San and Low Chai Ling.

Broker's Calls

Singapore Medial Group started at 'buy' on continued robust growth

SINGAPORE (Nov 13): DBS is initiating its “buy” call on Singapore Medical Group (SMG) with a target price of 75 cents on the back of continued robust growth post a successful turnaround.

Singapore Medical Group undertaking review of acquisitions strategies

SINGAPORE (April 24): Singapore Medical Group is undertaking a review of its current and future acquisitions strategies.
×